v3.25.1
Segment Information - Schedule of Segment Information (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 29, 2025
Mar. 30, 2024
Segment Reporting Information [Line Items]    
Revenues $ 5,514 $ 0
Gross profit 2,591 0
Operating loss (2,170) (1,806)
Depreciation and amortization 1,210 639
Interest expense, net 720 252
Net loss before income taxes (2,576) (2,219)
Fintech    
Segment Reporting Information [Line Items]    
Revenues 5,514 0
Gross profit 2,591 0
Operating loss (362) 0
Depreciation and amortization 728 0
Interest expense, net 376 0
Net loss before income taxes (346) 0
Biotech    
Segment Reporting Information [Line Items]    
Revenues 0 0
Gross profit 0 0
Operating loss (540) (701)
Depreciation and amortization 482 639
Interest expense, net 0 252
Net loss before income taxes (540) (701)
Corporate and other    
Segment Reporting Information [Line Items]    
Revenues 0 0
Gross profit 0 0
Operating loss (1,268) (1,105)
Depreciation and amortization 0 0
Interest expense, net 344 0
Net loss before income taxes $ (1,690) $ (1,518)